CellCura ASA (Oslo Axess: CELL) will publish the Annual Report 2013 report on Friday 9 May.
Oslo, 02 may 2014
CellCura ASA
Tore Viana-Rønningen
Chief Executive Officer
Phone: +47 911 08 693
CellCura ASA is dedicated to the development and sales of cell technologies for use in assisted reproductive technology (ART) and stem cell research worldwide, representing improved safety and efficiency compared to traditional technology. The company has customers in Belgium, Italy, Turkey, England, China and US. CellCura is listed on the Oslo Axess market at the Oslo Stock Exchange (ticker: CELL).
www.cellcura.com
This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)
distributed by |